Literature DB >> 24850872

Ethics and end of life care: the Liverpool Care Pathway and the Neuberger Review.

Anthony Wrigley.   

Abstract

The Liverpool Care Pathway for the Dying has recently been the topic of substantial media interest and also been subject to the independent Neuberger Review. This review has identified clear failings in some areas of care and recommended the Liverpool Care Pathway be phased out. I argue that while the evidence gathered of poor incidences of practice by the Review is of genuine concern for end of life care, the inferences drawn from this evidence are inconsistent with the causes for the concern. Seeking to end an approach that is widely seen as best practice and which can genuinely deliver high quality care because of negative impressions that have been formed from failing to implement it properly is not a good basis for radically overhauling our approach to end of life care. I conclude that improvements in training, communication and ethical decision-making, without the added demand to end the Liverpool Care Pathway, would have resulted in a genuine advance in end of life care. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Mesh:

Year:  2014        PMID: 24850872     DOI: 10.1136/medethics-2013-101780

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  9 in total

1.  International transfer and translation of an end of life care intervention: the case of the Liverpool Care Pathway for the dying patient.

Authors:  David Clark; Hamilton Inbadas; Jane Seymour
Journal:  Wellcome Open Res       Date:  2020-10-27

2.  Use of a modified Liverpool care pathway in a tertiary Asian hospital: is there still a role for it?

Authors:  Ong Eng Koon; Shirlyn Neo Hui Shan; Sushma Shivananda; Tan Yung Ying; Arrynoer Thang; Aung Myat Kyawt; Ulina Santoso; Grace Pang Su Yin; Alethea Yee Chung Pheng; Patricia Neo Soek Hui
Journal:  J Palliat Med       Date:  2015-02-26       Impact factor: 2.947

Review 3.  The Liverpool Care Pathway: discarded in cancer patients but good enough for dying nursing home patients? A systematic review.

Authors:  Bettina S Husebø; Elisabeth Flo; Knut Engedal
Journal:  BMC Med Ethics       Date:  2017-08-09       Impact factor: 2.652

4.  Experiences with the Liverpool care pathway for the dying patient in nursing home residents: a mixed-method study to assess physicians' and nurse practitioners' perceptions.

Authors:  Maartje S Klapwijk; Natashe Lemos Dekker; Monique A A Caljouw; Wilco P Achterberg; Jenny T van der Steen
Journal:  BMC Palliat Care       Date:  2020-11-30       Impact factor: 3.234

Review 5.  The changing nature of end of life care.

Authors:  Katrine Cauldwell; Paddy Stone
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Apr-Jun

6.  Caring for quality of care: symbolic violence and the bureaucracies of audit.

Authors:  Nathan Emmerich; Deborah Swinglehurst; Jo Maybin; Sophie Park; Sally Quilligan
Journal:  BMC Med Ethics       Date:  2015-05-08       Impact factor: 2.652

7.  The characteristics of patients who discontinue their dying process - an observational study at a single university hospital centre.

Authors:  Christian Schulz; Daniel Schlieper; Christiane Altreuther; Manuela Schallenburger; Katharina Fetz; Andrea Schmitz
Journal:  BMC Palliat Care       Date:  2015-12-07       Impact factor: 3.234

8.  Electronic Implementation of Integrated End-of-life Care: A Local Approach.

Authors:  Daniel Schlieper; Christiane Altreuther; Manuela Schallenburger; Martin Neukirchen; Andrea Schmitz; Christian Schulz-Quach
Journal:  Int J Integr Care       Date:  2017-06-20       Impact factor: 5.120

9.  Impact of the Liverpool Care Pathway on quality end-of- care in residential care homes and home care-Nurses' perceptions.

Authors:  Cecilia Olsson; Elisabeth Kling; Karina Grundel Persson; Maria Larsson
Journal:  Nurs Open       Date:  2019-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.